Celadon Pharmaceuticals Company Profile, Contacts & Intelligence

Pharmaceutical ManufacturingLondon, City of, United Kingdom18 employeesFounded 2018
3 contacts with email or phone data3 with email data1 with phone data
Employees
18
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 4 visible contacts

Celadon Pharmaceuticals Overview

Celadon Pharmaceuticals Plc is a UK based pharmaceutical company focused on the research, cultivation, manufacturing, and supply of breakthrough cannabis-based medicines. Founded in 2018 after cannabis was legalised for medicinal purposes, Celadon was one of the first companies to receive Home Office and MHRA licences to cultivate and produce high-THC medicines. In March 2022, Celadon listed on the AIM market of the London Stock Exchange – a huge milestone in the industry and the first since GW Pharma (who were acquired for $7bn by Jazz in 2021). The Company has a clear mission: to improve quality of life for patients most in need through breakthrough cannabis-based medicines. The primary focus is addressing the 8 million chronic pain sufferers in the UK, who currently have little alternative to opioids. Celadon has a 100,000 sq ft facility in the UK, comprising a large indoor hydroponic cultivation area, proprietary extraction and GMP standard API manufacturing, and an R&D and testing laboratory. It has been estimated by Canaccord that it would cost a new market entrant over £60m and 2-3 years minimum to replicated what Celadon has built in the UK. The Company's subsidiary, LVL Health, owns an MHRA conditionally approved clinical trial using cannabis-based medicines to treat chronic pain in the UK. The initial study is already live and interested patients can learn more here: www.lvlhealth.co.uk Moreover, Celadon has a 20% stake in Kingdom Therapeutics, an early-stage biopharma developed a licenced cannabinoid medicine for children with Autism Spectrum Disorder. This forms part of Celadon’s ‘Breakthrough R&D’ programme, which aims to develop novel IP (molecules, delivery technology) and the future of cannabis-based medicines. Learn more about Celadon here: www.celadonpharma.com

Headquarters
London, City of, United Kingdom
Industry
Pharmaceutical Manufacturing
Founded
2018
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Celadon Pharmaceuticals Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data and 1 with phone data in the visible sample.

Celadon Pharmaceuticals People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Celadon Pharmaceuticals Workforce Composition

Seniority breakdown across 4 visible profiles.

Executive
1
VP / Head
1
Director
1
Individual contributor
1

Compare Similar Companies to Celadon Pharmaceuticals

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Jazz Pharmaceuticals Pharmaceutical Manufacturing 3.45K View company
GW Pharmaceuticals plc Pharmaceutical Manufacturing 227 View company
Curaleaf Laboratories Pharmaceutical Manufacturing 67 View company
SOMAÍ Pharmaceutical Manufacturing 65 View company
Glass Pharms Pharmaceutical Manufacturing 16 View company
Dalgety Pharmaceutical Manufacturing 15 View company
Valeos Pharma A/S Pharmaceutical Manufacturing 15 View company
Phytome Life Sciences Pharmaceutical Manufacturing 13 View company
Kingdom Therapeutics Ltd Biotechnology Research 8 View company
Nogra Pharma Pharmaceutical Manufacturing 8 View company